Ropinirole: Side Effects, Uses & Monitoring
Parkinson’s Disease Ropinirole Hydrochloride Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease.
- Data source
- FDA labeling via NIH DailyMed (label c1c74e92…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Nausea | 60% |
| Dizziness | 40% |
| Somnolence | 40% |
| Dyskinesia | 34% |
| Headache | 17% |
| Syncope | 12% |
| Vomiting | 12% |
| Fatigue | 11% |
| Viral infection | 11% |
| Dyspepsia | 10% |
| Falls | 10% |
| Hallucinations | 10% |
| Upper respiratory tract infection | 9% |
| Nasopharyngitis | 9% |
| Pain | 8% |
| Leg edema | 7% |
| Increased drug level | 7% |
| Arthralgia | 7% |
| Increased sweating | 6% |
| Asthenia | 6% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
Parkinson’s Disease Ropinirole Hydrochloride Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. The effectiveness of Ropinirole Hydrochloride Tablets were demonstrated in randomized, controlled trials in patients with early Parkinson’s disease who were not receiving concomitant L-dopa therapy as well as in patients with advanced disease on concomitant L-dopa (see CLINICAL PHARMACOLOGY: Clinical Trials ). Restless Legs Syndrome Ropinirole Hydrochloride Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). Key diagnostic criteria for RLS are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. Difficulty falling asleep may frequently be associated with moderate-to-severe RLS.
Conditions associated with Ropinirole in labeling
Frequently Asked Questions
What is Ropinirole used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Ropinirole?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Ropinirole. Individual risk varies.
Does Ropinirole require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Ropinirole.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.